CA1129319A - In vitro testing method for the diagnosis of malignant tumours - Google Patents
In vitro testing method for the diagnosis of malignant tumoursInfo
- Publication number
- CA1129319A CA1129319A CA317,809A CA317809A CA1129319A CA 1129319 A CA1129319 A CA 1129319A CA 317809 A CA317809 A CA 317809A CA 1129319 A CA1129319 A CA 1129319A
- Authority
- CA
- Canada
- Prior art keywords
- layer
- migration
- capillary
- lymphocytes
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 54
- 238000003745 diagnosis Methods 0.000 title claims abstract description 7
- 201000011510 cancer Diseases 0.000 title claims abstract description 6
- 238000000338 in vitro Methods 0.000 title claims abstract description 6
- 230000005012 migration Effects 0.000 claims abstract description 42
- 238000013508 migration Methods 0.000 claims abstract description 42
- 239000000427 antigen Substances 0.000 claims abstract description 34
- 102000036639 antigens Human genes 0.000 claims abstract description 34
- 108091007433 antigens Proteins 0.000 claims abstract description 34
- 210000004698 lymphocyte Anatomy 0.000 claims abstract description 23
- 239000000725 suspension Substances 0.000 claims abstract description 22
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 21
- 230000005764 inhibitory process Effects 0.000 claims abstract description 18
- 229920001817 Agar Polymers 0.000 claims abstract description 16
- 239000008272 agar Substances 0.000 claims abstract description 15
- 239000011521 glass Substances 0.000 claims abstract description 10
- 239000012503 blood component Substances 0.000 claims abstract description 6
- 230000001413 cellular effect Effects 0.000 claims abstract description 6
- 239000007788 liquid Substances 0.000 claims abstract description 4
- 230000004936 stimulating effect Effects 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 20
- 108010074506 Transfer Factor Proteins 0.000 claims description 19
- 230000007704 transition Effects 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 4
- 238000002360 preparation method Methods 0.000 abstract description 15
- 238000010276 construction Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 34
- 210000004027 cell Anatomy 0.000 description 28
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 17
- 239000010410 layer Substances 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 15
- 235000010419 agar Nutrition 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000002609 medium Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 239000008188 pellet Substances 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 201000008275 breast carcinoma Diseases 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000003211 malignant effect Effects 0.000 description 7
- 229920000936 Agarose Polymers 0.000 description 6
- 201000009030 Carcinoma Diseases 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 125000000962 organic group Chemical group 0.000 description 6
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 101000794475 Schistosoma mansoni Calcium-binding protein Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 125000001475 halogen functional group Chemical group 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000004080 punching Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 206010001233 Adenoma benign Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 208000007659 Fibroadenoma Diseases 0.000 description 2
- 108010074338 Lymphokines Proteins 0.000 description 2
- 102000008072 Lymphokines Human genes 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 201000003149 breast fibroadenoma Diseases 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 210000003714 granulocyte Anatomy 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000001926 lymphatic effect Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 208000002699 Digestive System Neoplasms Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000017604 Hodgkin disease Diseases 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 101150100535 MIF3 gene Proteins 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000018259 Solanum vestissimum Nutrition 0.000 description 1
- 240000002825 Solanum vestissimum Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960001701 chloroform Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000002355 dual-layer Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 206010016629 fibroma Diseases 0.000 description 1
- 229960004279 formaldehyde Drugs 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEP2755363.5 | 1977-12-12 | ||
| DE2755363A DE2755363C3 (de) | 1977-12-12 | 1977-12-12 | Testverfahren zur Diagnose von Malignomen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1129319A true CA1129319A (en) | 1982-08-10 |
Family
ID=6025947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA317,809A Expired CA1129319A (en) | 1977-12-12 | 1978-12-12 | In vitro testing method for the diagnosis of malignant tumours |
Country Status (25)
| Country | Link |
|---|---|
| JP (1) | JPS54100176A (de) |
| AR (1) | AR220356A1 (de) |
| AT (1) | AT360178B (de) |
| AU (1) | AU4234978A (de) |
| BE (1) | BE872651A (de) |
| CA (1) | CA1129319A (de) |
| CH (1) | CH646793A5 (de) |
| DD (1) | DD139903A5 (de) |
| DE (1) | DE2755363C3 (de) |
| DK (1) | DK532678A (de) |
| ES (2) | ES475905A1 (de) |
| FI (1) | FI783782A7 (de) |
| FR (1) | FR2411412A1 (de) |
| GB (1) | GB2009927B (de) |
| GR (1) | GR66576B (de) |
| IL (1) | IL56152A0 (de) |
| IT (1) | IT1160323B (de) |
| LU (1) | LU80609A1 (de) |
| NL (1) | NL7811903A (de) |
| NO (1) | NO784096L (de) |
| PL (1) | PL112675B1 (de) |
| PT (1) | PT68891A (de) |
| RO (1) | RO75333A (de) |
| SE (1) | SE432157B (de) |
| ZA (1) | ZA786908B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4436824A (en) * | 1981-06-09 | 1984-03-13 | Ortho Diagnostic Systems, Inc. | Leukocyte migration through antigen containing agaroses for immunocompetence testing |
| JPH0672158B2 (ja) * | 1984-05-24 | 1994-09-14 | チバ−ガイギ− アクチエンゲゼルシヤフト | 精製されたヒトマクロファージ遊走阻止因子 |
-
1977
- 1977-12-12 DE DE2755363A patent/DE2755363C3/de not_active Expired
-
1978
- 1978-11-29 GR GR57767A patent/GR66576B/el unknown
- 1978-11-29 DK DK532678A patent/DK532678A/da unknown
- 1978-11-29 SE SE7812313A patent/SE432157B/sv unknown
- 1978-12-01 CH CH1232978A patent/CH646793A5/de not_active IP Right Cessation
- 1978-12-04 LU LU80609A patent/LU80609A1/de unknown
- 1978-12-06 AT AT872478A patent/AT360178B/de active
- 1978-12-06 NO NO784096A patent/NO784096L/no unknown
- 1978-12-06 NL NL7811903A patent/NL7811903A/xx not_active Application Discontinuation
- 1978-12-07 IL IL56152A patent/IL56152A0/xx unknown
- 1978-12-08 AU AU42349/78A patent/AU4234978A/en active Pending
- 1978-12-08 FI FI783782A patent/FI783782A7/fi unknown
- 1978-12-08 GB GB7847795A patent/GB2009927B/en not_active Expired
- 1978-12-08 DD DD78209631A patent/DD139903A5/de unknown
- 1978-12-09 RO RO7895854A patent/RO75333A/ro unknown
- 1978-12-11 ZA ZA00786908A patent/ZA786908B/xx unknown
- 1978-12-11 ES ES475905A patent/ES475905A1/es not_active Expired
- 1978-12-11 PT PT68891A patent/PT68891A/pt unknown
- 1978-12-11 FR FR7834749A patent/FR2411412A1/fr active Granted
- 1978-12-11 BE BE2057477A patent/BE872651A/xx not_active IP Right Cessation
- 1978-12-12 AR AR274770A patent/AR220356A1/es active
- 1978-12-12 CA CA317,809A patent/CA1129319A/en not_active Expired
- 1978-12-12 IT IT30722/78A patent/IT1160323B/it active
- 1978-12-12 JP JP15459078A patent/JPS54100176A/ja active Pending
- 1978-12-12 PL PL1978211672A patent/PL112675B1/pl unknown
-
1979
- 1979-05-25 ES ES1979243564U patent/ES243564Y/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS54100176A (en) | 1979-08-07 |
| DK532678A (da) | 1979-06-13 |
| PT68891A (en) | 1979-07-24 |
| IL56152A0 (en) | 1979-03-12 |
| AR220356A1 (es) | 1980-10-31 |
| SE432157B (sv) | 1984-03-19 |
| PL112675B1 (en) | 1980-10-31 |
| ES475905A1 (es) | 1979-10-16 |
| IT1160323B (it) | 1987-03-11 |
| GB2009927B (en) | 1982-10-06 |
| FR2411412A1 (fr) | 1979-07-06 |
| DE2755363B2 (de) | 1979-12-20 |
| AT360178B (de) | 1980-12-29 |
| RO75333A (ro) | 1980-11-30 |
| ES243564Y (es) | 1980-12-16 |
| DD139903A5 (de) | 1980-01-23 |
| IT7830722A0 (it) | 1978-12-12 |
| FI783782A7 (fi) | 1979-06-13 |
| CH646793A5 (de) | 1984-12-14 |
| BE872651A (nl) | 1979-03-30 |
| AU4234978A (en) | 1979-06-21 |
| DE2755363C3 (de) | 1983-12-01 |
| SE7812313L (sv) | 1979-06-13 |
| PL211672A1 (pl) | 1979-09-10 |
| GB2009927A (en) | 1979-06-20 |
| ES243564U (es) | 1980-06-01 |
| LU80609A1 (de) | 1979-05-16 |
| ATA872478A (de) | 1980-05-15 |
| NL7811903A (nl) | 1979-06-14 |
| GR66576B (de) | 1981-03-27 |
| NO784096L (no) | 1979-06-13 |
| ZA786908B (en) | 1979-12-27 |
| DE2755363A1 (de) | 1979-06-13 |
| FR2411412B3 (de) | 1981-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Smith et al. | The cells of human colostrum. I. In vitro studies of morphology and functions | |
| Weiner et al. | Serological findings in a case of haemolytic anaemia | |
| CA1129319A (en) | In vitro testing method for the diagnosis of malignant tumours | |
| Butler | Some studies on the naturally occurring leucocyte agglutinins | |
| Yunis et al. | Cell Antigens and Cell Specialization: I. A Study of Blood Group Antigens on Normoblasts | |
| CA2368423C (en) | Method for selectively separating blood cells by using lectin | |
| ISHIKO et al. | Anemia-inducing substance (AIS) in advanced cancer: inhibitory effect of AIS on the function of erythrocytes and immunocompetent cells | |
| Van Eden et al. | Low T lymphocyte responsiveness to Mycobacterium leprae antigens in association with HLA-DR3 | |
| CA1059902A (en) | Diagnostic process | |
| RU2130615C1 (ru) | Способ экспресс-диагностики туберкулеза на основе реакции латекс-агглютинации | |
| Goldberg et al. | Inhibition of macrophage migration: A test system using human monocytes | |
| CA1298182C (en) | Separation and use of density specific blood cells | |
| Fleekop et al. | Cellular inflammatory responces in human allergic skin reactions | |
| Han et al. | The behavior of leprous lymphocytes and macrophages in the macrophage migration-inhibition test | |
| Nordlind et al. | Leukocytes from patients allergic to chromium and nickel examined by the sealed capillary migration technique | |
| Jones et al. | Skin tests with nuclear factors in systemic lupus erythematosus | |
| EP0439548B1 (de) | Präparat von blutzellen spezifischer dichte für den scm-test | |
| Hauptmann et al. | ‘False positive’acidified serum test in a preleukemic dyserythropoiesis | |
| US3849546A (en) | Process for obtaining abtigenlipoid emulsions | |
| Guillet et al. | Increased erythrocyte rigidity in chronic alcoholics without cirrhosis: deformability improvement of erythrocyte sub-populations after alcohol withdrawal | |
| US4788143A (en) | Method for determining levels of cell-mediated immunity | |
| SU904669A1 (ru) | Способ диагностики генитального туберкулеза | |
| SU1018015A1 (ru) | Способ определени токсичности сыворотки крови | |
| SU1168206A1 (ru) | Способ дифференциальной диагностики неспецифического язвенного колита и бактериальной дизентерии | |
| RU2104544C1 (ru) | Способ выявления острого радиоактивного заражения организма |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |